Perl, Sabine

MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol

Parati, G., Agabiti-Rosei, E., Bakris, G. L., Bilo, G., Branzi, G., Cecchi, F., Chrostowska, M., De la Sierra, A., Domenech, M., Dorobantu, M., et al. (2018) · BMJ Open

Blood Pressure and Hypertension StudiesSodium Intake and Health

Cited by 39

Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trial

Verheyen, N., Fahrleitner-Pammer, A., Pieske, B., Meinitzer, A., Belyavskiy, E., Wetzel, J., Gaksch, M., Grübler, M. R., Catena, C., Sechi, L. A., et al. (2016) · Journal of Hypertension

Parathyroid Disorders and TreatmentsHormonal Regulation and Hypertension

Cited by 24

Plasma parathyroid hormone and cardiovascular disease in treatment‐naive patients with primary hyperparathyroidism: The EPATH trial

Wetzel, J., Pilz, S., Grübler, M. R., Fahrleitner‐Pammer, A., Dimai, H. P., von Lewinski, D., Kolesnik, E., Perl, S., Trummer, C., Schwetz, V., et al. (2017) · The Journal of Clinical Hypertension

Parathyroid Disorders and TreatmentsHormonal Regulation and Hypertension

Cited by 22